Moleculera Biosciences Patient Stories
Kids suffer from debilitating episodes after recovering from strep throat (Nightline-Part 1)
At age 10, Parker suddenly developed vocal tics, OCD, psychosis and hallucinations. His mental state was so concerning, he was admitted to a psychiatric hospital.
Watch patients describe how the Autoimmune Brain Panel™
(formerly the Cunningham Panel™) helped changed their lives.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.